Antibe Therapeutics Inc.

TSX:ATE Rapporto sulle azioni

Cap. di mercato: CA$15.6m

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

Antibe Therapeutics Gestione

Gestione criteri di controllo 1/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Dan Legault

Amministratore delegato

CA$784.9k

Compenso totale

Percentuale dello stipendio del CEO65.6%
Mandato del CEO15yrs
Proprietà del CEO2.1%
Durata media del management4.1yrs
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Is Antibe Therapeutics (TSE:ATE) In A Good Position To Invest In Growth?

Dec 15
Is Antibe Therapeutics (TSE:ATE) In A Good Position To Invest In Growth?

We Think Antibe Therapeutics (TSE:ATE) Needs To Drive Business Growth Carefully

Mar 20
We Think Antibe Therapeutics (TSE:ATE) Needs To Drive Business Growth Carefully

Antibe Therapeutics (TSE:ATE) Is In A Strong Position To Grow Its Business

Oct 16
Antibe Therapeutics (TSE:ATE) Is In A Strong Position To Grow Its Business

Antibe Therapeutics Inc.'s (TSE:ATE) Profit Outlook

Feb 11
Antibe Therapeutics Inc.'s (TSE:ATE) Profit Outlook

We're Keeping An Eye On Antibe Therapeutics' (TSE:ATE) Cash Burn Rate

Jan 07
We're Keeping An Eye On Antibe Therapeutics' (TSE:ATE) Cash Burn Rate

Auditors Are Concerned About Antibe Therapeutics (CVE:ATE)

Jul 31
Auditors Are Concerned About Antibe Therapeutics (CVE:ATE)

Need To Know: The Consensus Just Cut Its Antibe Therapeutics Inc. (CVE:ATE) Estimates For 2021

Jul 29
Need To Know: The Consensus Just Cut Its Antibe Therapeutics Inc. (CVE:ATE) Estimates For 2021

Analisi delle retribuzioni degli amministratori delegati

Come è cambiata la remunerazione di Dan Legault rispetto agli utili di Antibe Therapeutics?
DataCompenso totaleStipendioGuadagni aziendali
Dec 31 2023n/an/a

-CA$18m

Sep 30 2023n/an/a

-CA$18m

Jun 30 2023n/an/a

-CA$19m

Mar 31 2023CA$785kCA$515k

-CA$19m

Dec 31 2022n/an/a

-CA$21m

Sep 30 2022n/an/a

-CA$22m

Jun 30 2022n/an/a

-CA$24m

Mar 31 2022CA$715kCA$443k

-CA$25m

Dec 31 2021n/an/a

-CA$26m

Sep 30 2021n/an/a

-CA$26m

Jun 30 2021n/an/a

-CA$25m

Mar 31 2021CA$3mCA$357k

-CA$24m

Dec 31 2020n/an/a

-CA$25m

Sep 30 2020n/an/a

-CA$23m

Jun 30 2020n/an/a

-CA$21m

Mar 31 2020CA$1mCA$311k

-CA$19m

Dec 31 2019n/an/a

-CA$17m

Sep 30 2019n/an/a

-CA$16m

Jun 30 2019n/an/a

-CA$13m

Mar 31 2019CA$2mCA$311k

-CA$13m

Dec 31 2018n/an/a

-CA$11m

Sep 30 2018n/an/a

-CA$9m

Jun 30 2018n/an/a

-CA$8m

Mar 31 2018CA$273kCA$273k

-CA$7m

Compensazione vs Mercato: La retribuzione totale di Dan ($USD 576.21K ) è superiore alla media delle aziende di dimensioni simili nel mercato Canadian ($USD 176.00K ).

Compensazione vs guadagni: La retribuzione di Dan è aumentata nonostante l'azienda non sia redditizia.

AMMINISTRATORE DELEGATO

Dan Legault (65 yo)

15yrs

Mandato

CA$784,861

Compensazione

Mr. Daniel Marcel Legault, also known as Dan, J.D., L.L.B, served as the Independent Chairman at Klinik Health Ventures Corp. and served as its Independent Director since April 17, 2019 and served as its P...

Gruppo dirigente

NomePosizioneMandatoCompensazioneProprietà
Daniel Legault
President15yrsCA$784.86k2.13%
CA$ 333.2k
Alain Wilson
Chief Financial Officer8.4yrsCA$219.93k0.13%
CA$ 20.3k
Scott Curtis
Chief Operating Officer1.8yrsCA$316.21k0.22%
CA$ 33.9k
David Vaughan
Chief Development Officerno dataCA$423.61k0.050%
CA$ 7.9k
Joseph Stauffer
Chief Medical Officer4.1yrsCA$1.13m0.48%
CA$ 75.2k
Ana Stegic
Executive Director of Clinical Operations3yrsCA$263.34k0.079%
CA$ 12.3k
Christina Cameron
Vice President of Investor Relationsno dataNessun datoNessun dato
Philip Stern
Vice President of Communicationsno dataNessun datoNessun dato

4.1yrs

Durata media

65yo

Età media

Gestione esperta: Il team dirigenziale di ATE è considerato esperto (durata media dell'incarico 4.1 anni).